Process Development and Manufacturing Publications 

Anna Särnefält, Chaminda Salgado, Sabine Kuratli, Yousuf Naqvi, Rebecca Chandler. Host cell protein risks, detection, and control in vaccine manufacturing. Vaccine Insights April 2026; 5(2),107–132

Catherine Fleck-Vidal, Mike Whelan, Ingrid Kromann, Niels Thulstrup, Katie Smith, Bjørg Dystvold Nilsson, Tung Thanh Le, Sally Girgis-Hjoberg, Stig Tollefsen, T Anh Wartel, Laura Plant. Towards a coherent Nordic vision for vaccine R&D, manufacturing, and pandemic preparedness. Vaccine Insights April 2026; 5(3),95–106

Mitsutaka Kitano, Gene Malin et al. CEPI Workshop Report: Applying Disease X Vaccine Library and Knowledge Base Approaches to Severe Fever with Thrombocytopenia Syndrome (SFTS). Vaccines March 2026; 14(4):304

Guido Dietrich, Mauro Bernuzzi et al. Analysing Vaccine Manufacturing Supply Chain Disruptions for Pandemic Preparedness using Discrete-Event Simulation. General Economics February 2026

Claire J Standley, J Gabrielle Breugelmans, Amol Chaudhari, Neil Cherian, Arminder Deol, Danny Scarponi, Franz Schnetzinger, Andrew Hebbeler. Artificial intelligence for health security in Africa: Benefits, risks and opportunities. Epidemics November 2025; 53:100870

June Kim et al. Fast-Tracking Vaccine Manufacturing: CEPI’s Rapid Response Framework for the 100 Days Mission. Vaccines August 2025; 13(8)

Ramin Sabet-Azad, Catherine Hoath, Nicole Bézay and Anna Särnefält. The Platform Readiness Dashboard: A Tool for Evaluating Vaccine Platform Suitability for a Rapid Response to Epidemic and Pandemic Threats. Vaccines July 2025; 13(8)

Vishal Mukund Sonje and Valerie Chambard. Overcoming CMC, manufacturing, and supply chain challenges in vaccine production: a review of efforts in the Global South, with a focus on Africa. Vaccine Insights June 2025; 4(4)

Michael Anyadiegwu, Renske Hesselink, and Ingrid Kromann. The Need for Manufacturing Speed - Accelerating Vaccine Availability for Emergency Use Against Disease Threats. PDA Letter May 2025

Ingrid Kromann et al. Seven unresolved questions for vaccine science in 2025. Vaccine Insights March 2025; 4(1)

June Kim and Anna Särnefält. Advanced technologies enabling accessible and sustainable vaccine development and manufacturing for future pandemics. Vaccine Insights, October 2024; 3(7)

Franz Schnetzinger et al. Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release. Vaccines, September 2024; 12(9)

Anna Särnefält, Ranna Eardley-Patel, Diletta Magini, et al. A Strategic Guide to Improve and De-risk Vaccine Development: CEPI’s CMC Framework. Journal of Pharmaceutical Science and Technology July 2024; 28(4)

Renske Hesselink et al. Improving vaccine equity by increasing vaccine thermostability. Science Translational Medicine July 2024; 16(757)

Ranna Eardley-Patel et al. The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation.  The Lancet October 2023; 402(10412)

Ingrid Kromann, Anna Särnefält et al. Availability and use of Standards in vaccine development. Vaccines June 2023; 8(95)

Renske Hesselink et al. Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities. Expert Opinion on Drug Delivery January 2023; 20(3)

Matthew Downham Vaccine manufacturing: the future is global. Vaccine Insights November 2022; 1(6)

Benoit Hayman, Rajinder Kumar Suri and Matthew Downham. Sustainable vaccine manufacturing in low- and middle-Income countries. Vaccine November 2022; 40(50)